Dave C. Morris
About Dave C. Morris
Dave C. Morris serves as the Vice President of Research Operations at Precision BioSciences, Inc. He has extensive experience in pharmaceutical research and development, specializing in target and hit discovery, lead optimization, and enterprise leadership.
Current Role at Precision BioSciences
Dave C. Morris serves as the Vice President of Research Operations at Precision BioSciences, Inc. since 2019. In this role, he oversees research initiatives and operations, contributing to the company's focus on innovative biotechnology solutions. His leadership is instrumental in advancing the company's research agenda and ensuring efficient operational processes.
Previous Experience at UNC Eshelman School of Pharmacy
From 2016 to 2019, Morris worked at the UNC Eshelman School of Pharmacy as the Associate Director of the UNC Catalyst for Rare Diseases. During his tenure, he played a significant role in advancing research initiatives aimed at addressing rare diseases, collaborating with various stakeholders to enhance research outcomes.
Background in Pharmaceutical Research
Morris has extensive experience in the pharmaceutical R&D sector, specializing in target and hit discovery as well as lead optimization. His career includes a notable position as VP of Biological Sciences at GSK, where he worked for 22 years. His broad therapeutic expertise encompasses metabolic, dermatology, and infectious disease areas.
Educational Qualifications
Morris earned his Ph.D. in Cell Biology with a focus on Biomineralization from the University of Liverpool, where he studied from 1976 to 1981. He also completed a Post-doctoral Fellowship in Metabolic Bone Disease at the University of Kansas Medical Center from 1981 to 1984. Additionally, he obtained a Certificate in Organizational Development from American University in partnership with the GlaxoWellcome Leadership Institute.
Consulting and Leadership Experience
In addition to his current role, Morris is the Founder and Principal Consultant at Collaborative Pharma Consulting, LLC, established in 2015. He has a proven record of successful enterprise leadership and collaborative working in the pharmaceutical industry, with extensive experience leading research teams across the US and Europe.